Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

22 Feb 2021

Mindset Pharma Reaches Agreement to Manufacture Large Quantity of Pharmaceutical Grade Psilocybin Using Patent-Pending Synthesis Process

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

22 Feb 2021

Havn Life announces DTC Eligibility of Its Common Shares in the United States

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

19 Feb 2021

Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial

London, United Kingdom–(Newsfile Corp....

By Microdose

Press Releases

19 Feb 2021

Mindset Pharma Added to North American Psychedelics Index

Toronto, Ontario–(Newsfile Corp....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

18 Feb 2021

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Trial enters pre-implementation stage having met several key milestones towards expanding access to patients with PTSD VANCOUVER, BC, Feb....

By Microdose

Press Releases

18 Feb 2021

Pure Extracts and Canada House Wellness Group sign agreement to distribute concentrate products through existing provincial distribution channels

VANCOUVER, British Columbia, Feb....

By Microdose

Press Releases

17 Feb 2021

Tryp Therapeutics Completes $2 Million Strategic Financing

La Jolla, California–(Newsfile Corp....

By Microdose

Press Releases

17 Feb 2021

Psychedelic Partnership Reached, Ehave Inc. and Brain Scientific Sign Memorandum of Understanding to Map Brain Response to Psychedelic Treatment, Collaborate in the Development of Neural Net Algorithms for the Psychedelic Mental Health Sector, E-Tattoo Technology is Expected to Provide Continuous Monitoring

Ehave, Inc....

By Microdose

Press Releases

17 Feb 2021

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

DENVER, Feb....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result